Thus, we determined the expression level of well-known EMT markers, including E-cadherin, Snail, Vimentin, and Zeb1, through RT-qPCR and immunofluorescence assays to assess whether PNKY can induce EMT in breast cancer cells. This evidence concerns the gene CDH1 and breast carcinoma.